Xcout IntelCereVasc, Inc.
CereVasc, Inc. is a neurological device company developing the eShunt System for the treatment of patients with communicating hydrocephalus.
Subscribe to see CereVasc, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CereVasc, Inc. at a glance
CereVasc, Inc. is a healthcare company headquartered in United States. It has raised at least $166.1M across the 3 funding rounds on record. Its most recent funding round, Series C, raised $85M in June 2026. Xcout tracks 7 named people at CereVasc, Inc., including Dan Levangie (Chairman and Chief Executive Officer).
CereVasc, Inc. leadership
- Dan LevangieChairman and Chief Executive Officer
- Daniel LevangiePresident & Chief Executive Officer
- Adel MalekCo-founder & Chief Medical Officer
- DJ CassSVP, Business Development & Strategy
- Chris DimlerVP, Operations & Engineering
- Ona WheloveVP, Clinical Operations
1 more named person on record for CereVasc, Inc., with roles, board committees and tenure — see the full roster →
CereVasc, Inc. funding rounds
At least $166.1M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $85M | 9 named | |
| Series C | $70M | 5 named | |
| SEC Form D filing | $11.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get CereVasc, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CereVasc, Inc. in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access